Renaissance Technologies’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45M Sell
1,521,170
-94,879
-6% -$2.81M 0.06% 378
2025
Q1
$48.2M Sell
1,616,049
-45,500
-3% -$1.36M 0.07% 335
2024
Q4
$47.6M Buy
1,661,549
+5,480
+0.3% +$157K 0.07% 340
2024
Q3
$64M Buy
1,656,069
+124,571
+8% +$4.81M 0.1% 253
2024
Q2
$49.3M Buy
1,531,498
+113,300
+8% +$3.65M 0.08% 298
2024
Q1
$55.1M Buy
1,418,198
+33,600
+2% +$1.3M 0.09% 285
2023
Q4
$42.6M Buy
1,384,598
+212,000
+18% +$6.53M 0.07% 342
2023
Q3
$26.2M Sell
1,172,598
-102,400
-8% -$2.29M 0.04% 459
2023
Q2
$27.4M Buy
1,274,998
+66,500
+6% +$1.43M 0.04% 527
2023
Q1
$29M Buy
1,208,498
+54,179
+5% +$1.3M 0.04% 546
2022
Q4
$26.8M Sell
1,154,319
-86,499
-7% -$2.01M 0.04% 583
2022
Q3
$19.9M Sell
1,240,818
-156,000
-11% -$2.5M 0.03% 679
2022
Q2
$24.8M Buy
1,396,818
+126,700
+10% +$2.25M 0.03% 626
2022
Q1
$25.9M Buy
1,270,118
+13,800
+1% +$281K 0.03% 622
2021
Q4
$23.5M Sell
1,256,318
-48,679
-4% -$909K 0.03% 630
2021
Q3
$25.8M Buy
1,304,997
+55,479
+4% +$1.1M 0.03% 559
2021
Q2
$29.5M Sell
1,249,518
-16,200
-1% -$383K 0.04% 540
2021
Q1
$30M Sell
1,265,718
-117,000
-8% -$2.77M 0.04% 559
2020
Q4
$27.7M Sell
1,382,718
-47,700
-3% -$955K 0.03% 597
2020
Q3
$29.8M Sell
1,430,418
-196,900
-12% -$4.1M 0.03% 563
2020
Q2
$28.5M Buy
1,627,318
+40,700
+3% +$712K 0.02% 638
2020
Q1
$25.9M Buy
1,586,618
+334,290
+27% +$5.46M 0.03% 651
2019
Q4
$25.8M Buy
1,252,328
+505,128
+68% +$10.4M 0.02% 865
2019
Q3
$8.58M Buy
747,200
+503,100
+206% +$5.78M 0.01% 1485
2019
Q2
$3.21M Buy
+244,100
New +$3.21M ﹤0.01% 2080
2018
Q2
Sell
-13,500
Closed -$345K 3291
2018
Q1
$345K Sell
13,500
-117,300
-90% -$3M ﹤0.01% 3024
2017
Q4
$2.42M Buy
+130,800
New +$2.42M ﹤0.01% 2234
2016
Q1
Sell
-11,933
Closed -$328K 3386
2015
Q4
$328K Sell
11,933
-19,867
-62% -$546K ﹤0.01% 2860
2015
Q3
$703K Buy
+31,800
New +$703K ﹤0.01% 2516